Back

IASLC-TTLC 2021 - IASLC 2021 Targeted Therapies of Lung Cancer (Virtual Meeting)

Feb 17 - Mar 04, 2021 | Santa MonicaCAUS

LARVOL is not affiliated with IASLC 2021 Targeted Therapies of Lung Cancer (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 4 abstracts linked to Trials

[VIRTUAL] The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC

5 Twitter Reactions

[VIRTUAL] Neratinib Efficacy in Patients with EGFR Exon 18-Mutant Non-Small Cell Lung Cancer (NSCLC): Findings from the SUMMIT Basket Trial

3 Twitter Reactions

[VIRTUAL] Precision Targeted Therapy for RET-driven NSCLC and Emerging Evidence of Acquired Resistance to RET-Specific Tyrosine Kinase Inhibitors

1 Twitter Reactions

[VIRTUAL] Detection of DNA Replication Blocker SLFN11 in Tumor Tissue and Circulating Tumor Cells to Predict Platinum Response in Small Cell Lung Cancer

  • Poster